chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Oral discomfort, Vaccination site pain
Clinical narrative: Arm hurt a bit; Was fatigue; Nausea; Lip felt feverish; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm hurt a bit), FATIGUE (Was fatigue), NAUSEA (Nausea) and ORAL DISCOMFORT (Lip felt feverish) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm hurt a bit), FATIGUE (Was fatigue), NAUSEA (Nausea) and ORAL DISCOMFORT (Lip felt feverish). At the time of the report, VACCINATION SITE PAIN (Arm hurt a bit), FATIGUE (Was fatigue), NAUSEA (Nausea) and ORAL DISCOMFORT (Lip felt feverish) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information provided. No treatment information provided.
Age: 69.0
Sex: U
Vaccine: COVID19
Symptoms: Headache, Hot flush, Pruritus, Pyrexia, Rash
Clinical narrative: itchiness of hands and wrist; rash on extremities; hot flashes; raised temp; headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (raised temp), HEADACHE (headache), HOT FLUSH (hot flashes), PRURITUS (itchiness of hands and wrist) and RASH (rash on extremities) in a 69-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced PYREXIA (raised temp) and HEADACHE (headache). On 05-Feb-2021, the patient experienced HOT FLUSH (hot flashes). On 07-Feb-2021, the patient experienced PRURITUS (itchiness of hands and wrist) and RASH (rash on extremities). At the time of the report, PYREXIA (raised temp), HEADACHE (headache), HOT FLUSH (hot flashes), PRURITUS (itchiness of hands and wrist) and RASH (rash on extremities) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information provided. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Suspected COVID-19
Clinical narrative: Felt like she had COVID-19 all over again; Aches in her joints; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (Felt like she had COVID-19 all over again), ARTHRALGIA (Aches in her joints), HEADACHE (Headache) and CHILLS (Chills) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced SUSPECTED COVID-19 (Felt like she had COVID-19 all over again), ARTHRALGIA (Aches in her joints), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, SUSPECTED COVID-19 (Felt like she had COVID-19 all over again), ARTHRALGIA (Aches in her joints), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications reported. no treatment details reported.   This case was linked to MOD21-038267 (E2B Linked Report).; Sender's Comments:  MOD21-038267:same reporter
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: itchy rash after a week spreading through her body; itchy rash after a week spreading through her body; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PRURITUS (itchy rash after a week spreading through her body) and VACCINATION SITE RASH (itchy rash after a week spreading through her body) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Asthma. Concomitant products included SALBUTAMOL (ALBUTEROL HFA), ATENOLOL, ESTRADIOL, FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF), FUROSEMIDE SODIUM (FUROSEMIDE ACCORD [FUROSEMIDE SODIUM]), LISINOPRIL, OMEPRAZOLE (OMEPRAZOL 1 A PHARMA), LEVOTHYROXINE SODIUM (SYNTHROID) and MAGNESIUM.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itchy rash after a week spreading through her body) and VACCINATION SITE RASH (itchy rash after a week spreading through her body). At the time of the report, VACCINATION SITE PRURITUS (itchy rash after a week spreading through her body) and VACCINATION SITE RASH (itchy rash after a week spreading through her body) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included Hydrocortisone
Sex: F
Vaccine: COVID19
Symptoms: Gastrooesophageal reflux disease, Vaccination site pain
Clinical narrative: gerd; Pain at injection; This spontaneous case was reported by a consumer and describes the occurrence of GASTROOESOPHAGEAL REFLUX DISEASE (gerd) and VACCINATION SITE PAIN (Pain at injection) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031LZ0A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE (gerd) and VACCINATION SITE PAIN (Pain at injection). The patient was treated with VITAMIN D3 ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, GASTROOESOPHAGEAL REFLUX DISEASE (gerd) and VACCINATION SITE PAIN (Pain at injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication include Omeprazole.
Sex: U
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: Adverse reaction to the moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Adverse reaction to the moderna vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Adverse reaction to the moderna vaccine). At the time of the report, ADVERSE REACTION (Adverse reaction to the moderna vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information provided. No treatment information provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Fatigue, Hypersomnia, Pain
Clinical narrative: loss of apetite; loss of energy; Hard Time Staying Awake; Vomiting; Aches; Fatigue; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Aches), DECREASED APPETITE (loss of apetite), ASTHENIA (loss of energy), HYPERSOMNIA (Hard Time Staying Awake) and FATIGUE (Fatigue) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 13-Oct-2020 and Cardiac pacemaker insertion. Concurrent medical conditions included Atrial fibrillation and Blood pressure fluctuation. Concomitant products included LOSARTAN, APIXABAN (ELIQUIS), PROPAFENONE HYDROCHLORIDE and DORZOLAMIDE HYDROCHLORIDE, TIMOLOL MALEATE (DORZOLAMIDE TIMOLOL) for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PAIN (Aches), FATIGUE (Fatigue) and PYREXIA (fever). On 02-Feb-2021, the patient experienced ASTHENIA (loss of energy), HYPERSOMNIA (Hard Time Staying Awake) and VOMITING (Vomiting). On an unknown date, the patient experienced DECREASED APPETITE (loss of apetite). On 07-Feb-2021, ASTHENIA (loss of energy), HYPERSOMNIA (Hard Time Staying Awake) and VOMITING (Vomiting) had resolved. At the time of the report, PAIN (Aches), DECREASED APPETITE (loss of apetite), FATIGUE (Fatigue) and PYREXIA (fever) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment information was not provided.   This case was linked to MOD-2021-210380 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Follow-up received : Updated reporters contact details (address), patient demographics, lab test, concomitant medications and additional events (asthenia, decreased appetite) were provided; outcome of events (vomiting, hypersomnia) were updated to recovered.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: loss of apetite; loss of energy; Hard Time Staying Awake; Vomiting; Aches; Fatigue; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Aches), DECREASED APPETITE (loss of apetite), ASTHENIA (loss of energy), HYPERSOMNIA (Hard Time Staying Awake) and FATIGUE (Fatigue) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 13-Oct-2020 and Cardiac pacemaker insertion. Concurrent medical conditions included Atrial fibrillation and Blood pressure fluctuation. Concomitant products included LOSARTAN, APIXABAN (ELIQUIS), PROPAFENONE HYDROCHLORIDE and DORZOLAMIDE HYDROCHLORIDE, TIMOLOL MALEATE (DORZOLAMIDE TIMOLOL) for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PAIN (Aches), FATIGUE (Fatigue) and PYREXIA (fever). On 02-Feb-2021, the patient experienced ASTHENIA (loss of energy), HYPERSOMNIA (Hard Time Staying Awake) and VOMITING (Vomiting). On an unknown date, the patient experienced DECREASED APPETITE (loss of apetite). On 07-Feb-2021, ASTHENIA (loss of energy), HYPERSOMNIA (Hard Time Staying Awake) and VOMITING (Vomiting) had resolved. At the time of the report, PAIN (Aches), DECREASED APPETITE (loss of apetite), FATIGUE (Fatigue) and PYREXIA (fever) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment information was not provided.   This case was linked to MOD-2021-210380 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Follow-up received : Updated reporters contact details (address), patient demographics, lab test, concomitant medications and additional events (asthenia, decreased appetite) were provided; outcome of events (vomiting, hypersomnia) were updated to recovered.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site rash
Clinical narrative: red rash around the injection site,red rash was approximately 5" X 7" in size; twinge of itching,left arm became unbearably itchy,; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (twinge of itching,left arm became unbearably itchy,) and VACCINATION SITE RASH (red rash around the injection site,red rash was approximately 5" X 7" in size) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Celebrex,gabapentin, ibuprofen, levofloxacin), Celiac disease and Allergy to antibiotic (Ceftin, doxycycline, Z-pack, clindamycin).    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 04-Feb-2021, the patient experienced PRURITUS (twinge of itching,left arm became unbearably itchy,). On 13-Feb-2021, the patient experienced VACCINATION SITE RASH (red rash around the injection site,red rash was approximately 5" X 7" in size). The patient was treated with CORTISONE at an unspecified dose and frequency and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at an unspecified dose and frequency. On 16-Feb-2021, VACCINATION SITE RASH (red rash around the injection site,red rash was approximately 5" X 7" in size) had resolved. At the time of the report, PRURITUS (twinge of itching,left arm became unbearably itchy,) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Oropharyngeal pain, Vaccination site pain
Clinical narrative: Nauseous; Sore throat; had slight sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (had slight sore arm), NAUSEA (Nauseous) and OROPHARYNGEAL PAIN (Sore throat) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K208 and 043L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE PAIN (had slight sore arm). On 06-Feb-2021, the patient experienced NAUSEA (Nauseous) and OROPHARYNGEAL PAIN (Sore throat). On 07-Feb-2021, NAUSEA (Nauseous) had resolved. At the time of the report, VACCINATION SITE PAIN (had slight sore arm) and OROPHARYNGEAL PAIN (Sore throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information provided. No treatment information provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot
Clinical narrative: Redness appeared again, one week ago. Feeling good now.; Redness in same arm of injection, but further down in the arm.; Hot at the redness site; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness in same arm of injection, but further down in the arm.), FEELING HOT (Hot at the redness site) and ERYTHEMA (Redness appeared again, one week ago. Feeling good now.) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, Arthritis, Hypertension, Neuropathy (Neuropathy medication for liver) and Heart disorder. Concomitant products included METOPROLOL SUCCINATE (TOPROL) for Heart disorder.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced ERYTHEMA (Redness in same arm of injection, but further down in the arm.) and FEELING HOT (Hot at the redness site). On 18-Feb-2021, the patient experienced ERYTHEMA (Redness appeared again, one week ago. Feeling good now.). At the time of the report, ERYTHEMA (Redness in same arm of injection, but further down in the arm.), FEELING HOT (Hot at the redness site) and ERYTHEMA (Redness appeared again, one week ago. Feeling good now.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment included Tylenol
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse event, Urticaria
Clinical narrative: Full body hives; mild symptoms; This spontaneous case was reported by a physician and describes the occurrence of ADVERSE EVENT (mild symptoms) and URTICARIA (Full body hives) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced ADVERSE EVENT (mild symptoms). On 02-Feb-2021, the patient experienced URTICARIA (Full body hives). At the time of the report, ADVERSE EVENT (mild symptoms) and URTICARIA (Full body hives) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Treatment included - She has been self-medicating with Benadryl and perhaps getting better but she is not sure.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: itch; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itch) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itch). At the time of the report, PRURITUS (itch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information provided. No treatment information provided.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: pregnant; This spontaneous prospective pregnancy case was reported by a health care professional and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnant) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 05-Aug-2021. On 13-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnant). On 13-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered MATERNAL EXPOSURE DURING PREGNANCY (pregnant) to be not related.    Concomitant medications were not reported.; Reporter's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 31-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: Itchy rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itchy rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH PRURITIC (Itchy rash). At the time of the report, RASH PRURITIC (Itchy rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lethargy, Rash macular, Vaccination site warmth
Clinical narrative: warmth at the injection site; red blotchiness at the injection site; headaches; lethargic; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches), LETHARGY (lethargic), VACCINATION SITE WARMTH (warmth at the injection site) and RASH MACULAR (red blotchiness at the injection site) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LISDEXAMFETAMINE MESILATE (VYVANSE), AMOXICILLIN TRIHYDRATE (FLEMOXIN SOLUTAB), CALCIUM and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced HEADACHE (headaches) and LETHARGY (lethargic). On 06-Feb-2021, the patient experienced VACCINATION SITE WARMTH (warmth at the injection site) and RASH MACULAR (red blotchiness at the injection site). At the time of the report, HEADACHE (headaches), LETHARGY (lethargic), VACCINATION SITE WARMTH (warmth at the injection site) and RASH MACULAR (red blotchiness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Tylenol
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Joint swelling, Lip swelling, Pruritus, Rash
Clinical narrative: swollen ankle; swollen lip; swollen left eye; lumpy hives; itchy rash; hives; rash on lower extremities; itching; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PRURITUS (itching), URTICARIA (lumpy hives), URTICARIA (hives), LIP SWELLING (swollen lip) and EYE SWELLING (swollen left eye) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 007M201) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety. Concomitant products included DESVENLAFAXINE SUCCINATE MONOHYDRATE (PRISTIQ) for Anxiety, PARACETAMOL (TYLENOL) for Neck pain.   On 02-Jan-2021 at 3:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021 at 3:10 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Jan-2021, the patient experienced PRURITUS (itching) and RASH (rash on lower extremities). On 08-Jan-2021, the patient experienced URTICARIA (hives). On 10-Jan-2021, the patient experienced RASH PRURITIC (itchy rash). On 02-Feb-2021, the patient experienced URTICARIA (lumpy hives). On 09-Feb-2021, the patient experienced LIP SWELLING (swollen lip) and EYE SWELLING (swollen left eye). On 27-Feb-2021, the patient experienced JOINT SWELLING (swollen ankle). At the time of the report, PRURITUS (itching), URTICARIA (lumpy hives), LIP SWELLING (swollen lip), EYE SWELLING (swollen left eye), RASH PRURITIC (itchy rash), JOINT SWELLING (swollen ankle) and RASH (rash on lower extremities) outcome was unknown and URTICARIA (hives) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment drugs included OTC ALLEGRA, XYZAL, ZYRTEC, BENADRYL, IV SOLUMEDROL, IVBENADRYL, IV PEPCID, PREDNISONE, DOXEPIN, SINGULAIR, XOLAIR and MEDROL   This case was linked to MOD-2021-027466 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Significant follow up: event updated, Treatment information updated
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic, Urticaria
Clinical narrative: swollen ankle; swollen lip; swollen left eye; lumpy hives; itchy rash; hives; rash on lower extremities; itching; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PRURITUS (itching), URTICARIA (lumpy hives), URTICARIA (hives), LIP SWELLING (swollen lip) and EYE SWELLING (swollen left eye) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 007M201) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety. Concomitant products included DESVENLAFAXINE SUCCINATE MONOHYDRATE (PRISTIQ) for Anxiety, PARACETAMOL (TYLENOL) for Neck pain.   On 02-Jan-2021 at 3:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021 at 3:10 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Jan-2021, the patient experienced PRURITUS (itching) and RASH (rash on lower extremities). On 08-Jan-2021, the patient experienced URTICARIA (hives). On 10-Jan-2021, the patient experienced RASH PRURITIC (itchy rash). On 02-Feb-2021, the patient experienced URTICARIA (lumpy hives). On 09-Feb-2021, the patient experienced LIP SWELLING (swollen lip) and EYE SWELLING (swollen left eye). On 27-Feb-2021, the patient experienced JOINT SWELLING (swollen ankle). At the time of the report, PRURITUS (itching), URTICARIA (lumpy hives), LIP SWELLING (swollen lip), EYE SWELLING (swollen left eye), RASH PRURITIC (itchy rash), JOINT SWELLING (swollen ankle) and RASH (rash on lower extremities) outcome was unknown and URTICARIA (hives) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment drugs included OTC ALLEGRA, XYZAL, ZYRTEC, BENADRYL, IV SOLUMEDROL, IVBENADRYL, IV PEPCID, PREDNISONE, DOXEPIN, SINGULAIR, XOLAIR and MEDROL   This case was linked to MOD-2021-027466 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Significant follow up: event updated, Treatment information updated
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Headache, Myalgia
Clinical narrative: Headache; Nausea; Covid-19; Coughing; Sore throat; Body aches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19), COUGH (Coughing), OROPHARYNGEAL PAIN (Sore throat), MYALGIA (Body aches) and CHILLS (Chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history was not reported .  Concomitant products included ABATACEPT (ORENCIA) for Rheumatoid arthritis.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced COVID-19 (Covid-19), COUGH (Coughing), OROPHARYNGEAL PAIN (Sore throat), MYALGIA (Body aches) and CHILLS (Chills). On an unknown date, the patient experienced HEADACHE (Headache) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and GUAIFENESIN (MUCINEX) at an unspecified dose and frequency. At the time of the report, COVID-19 (Covid-19), COUGH (Coughing), OROPHARYNGEAL PAIN (Sore throat), MYALGIA (Body aches), CHILLS (Chills), HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Oropharyngeal pain
Clinical narrative: Headache; Nausea; Covid-19; Coughing; Sore throat; Body aches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19), COUGH (Coughing), OROPHARYNGEAL PAIN (Sore throat), MYALGIA (Body aches) and CHILLS (Chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history was not reported .  Concomitant products included ABATACEPT (ORENCIA) for Rheumatoid arthritis.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced COVID-19 (Covid-19), COUGH (Coughing), OROPHARYNGEAL PAIN (Sore throat), MYALGIA (Body aches) and CHILLS (Chills). On an unknown date, the patient experienced HEADACHE (Headache) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and GUAIFENESIN (MUCINEX) at an unspecified dose and frequency. At the time of the report, COVID-19 (Covid-19), COUGH (Coughing), OROPHARYNGEAL PAIN (Sore throat), MYALGIA (Body aches), CHILLS (Chills), HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Nausea, Pain in extremity, Pyrexia
Clinical narrative: Was shaking so bad; Nauseas; Fever up to 103.6F; Felt tired; Sore left arm; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Sore left arm), TREMOR (Was shaking so bad), NAUSEA (Nauseas), PYREXIA (Fever up to 103.6F) and FATIGUE (Felt tired) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis. Concomitant products included TRAMADOL for Arthritis, CLONAZEPAM for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore left arm) and FATIGUE (Felt tired). On 07-Feb-2021, the patient experienced TREMOR (Was shaking so bad), NAUSEA (Nauseas) and PYREXIA (Fever up to 103.6F). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore left arm), TREMOR (Was shaking so bad), NAUSEA (Nauseas), PYREXIA (Fever up to 103.6F) and FATIGUE (Felt tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Body temperature: 103.6f (Inconclusive) fever up to 103.6F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Was shaking so bad; Nauseas; Fever up to 103.6F; Felt tired; Sore left arm; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Sore left arm), TREMOR (Was shaking so bad), NAUSEA (Nauseas), PYREXIA (Fever up to 103.6F) and FATIGUE (Felt tired) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis. Concomitant products included TRAMADOL for Arthritis, CLONAZEPAM for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore left arm) and FATIGUE (Felt tired). On 07-Feb-2021, the patient experienced TREMOR (Was shaking so bad), NAUSEA (Nauseas) and PYREXIA (Fever up to 103.6F). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore left arm), TREMOR (Was shaking so bad), NAUSEA (Nauseas), PYREXIA (Fever up to 103.6F) and FATIGUE (Felt tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Body temperature: 103.6f (Inconclusive) fever up to 103.6F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Tingling; Swollen arm; 3inches by 2inches of red itchy circle in her arm; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling), VACCINATION SITE SWELLING (Swollen arm) and VACCINATION SITE ERYTHEMA (3inches by 2inches of red itchy circle in her arm) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. D0LM20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, the patient experienced PARAESTHESIA (Tingling), VACCINATION SITE SWELLING (Swollen arm) and VACCINATION SITE ERYTHEMA (3inches by 2inches of red itchy circle in her arm). At the time of the report, PARAESTHESIA (Tingling), VACCINATION SITE SWELLING (Swollen arm) and VACCINATION SITE ERYTHEMA (3inches by 2inches of red itchy circle in her arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Enuresis
Clinical narrative: Enuresis; This spontaneous case was reported by a consumer and describes the occurrence of ENURESIS (Enuresis) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported ).   On 05-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ENURESIS (Enuresis). At the time of the report, ENURESIS (Enuresis) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported   No treatment medication reported
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dysphonia
Clinical narrative: coughing a lot; losing her voice; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (coughing a lot) and DYSPHONIA (losing her voice) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Allergic reaction to antibiotics, Drug allergy (Aspirin allergy) and Drug allergy (Lipitor allergy).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced COUGH (coughing a lot) and DYSPHONIA (losing her voice). At the time of the report, COUGH (coughing a lot) and DYSPHONIA (losing her voice) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other relevant medication history included blood pressure medicine. No treatment information was provided.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Headache, Pain, Vaccination site mass
Clinical narrative: Felt off and no energy; Sore; A bit of a knot around injection site; Severely itchy; Felt tired; headache; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Felt off and no energy), PAIN (Sore), VACCINATION SITE MASS (A bit of a knot around injection site), VACCINATION SITE PRURITUS (Severely itchy) and FATIGUE (Felt tired) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heart attack (2 heart attacks in the past.), Broken hip and Stent placement (3 stents). Concurrent medical conditions included Neuropathy (Neuropathy in feet) and Diabetes. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81), ARFORMOTEROL TARTRATE (BROVANA), CARVEDILOL (COREG), RALOXIFENE HYDROCHLORIDE (EVISTA), SITAGLIPTIN PHOSPHATE (JANUVIA), ATORVASTATIN CALCIUM (LIPITOR), MAGNESIUM OXIDE, LEVOTHYROXINE SODIUM (SYNTHROID), VITAMIN D [VITAMIN D NOS], VITAMIN A NOS, FLUOXETINE HYDROCHLORIDE (PROZAC), EZETIMIBE (ZETIA), MONTELUKAST SODIUM (SINGULAIR), OXYBUTYNIN, IRON, VITAMIN C [ASCORBIC ACID] and ALPRAZOLAM (XANAX) for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Felt off and no energy), PAIN (Sore), VACCINATION SITE MASS (A bit of a knot around injection site), VACCINATION SITE PRURITUS (Severely itchy), FATIGUE (Felt tired) and HEADACHE (headache). At the time of the report, ASTHENIA (Felt off and no energy), PAIN (Sore), VACCINATION SITE MASS (A bit of a knot around injection site), FATIGUE (Felt tired) and HEADACHE (headache) outcome was unknown and VACCINATION SITE PRURITUS (Severely itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication including trilogy  was also reported  No treatment medication was reported    Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Concomitant medication list updated, new events updated and start dates updated, second dose details updated On 06-May-2021: Follow-up information received on 06-MAY-2021 contains non-significant information
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: Felt off and no energy; Sore; A bit of a knot around injection site; Severely itchy; Felt tired; headache; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Felt off and no energy), PAIN (Sore), VACCINATION SITE MASS (A bit of a knot around injection site), VACCINATION SITE PRURITUS (Severely itchy) and FATIGUE (Felt tired) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heart attack (2 heart attacks in the past.), Broken hip and Stent placement (3 stents). Concurrent medical conditions included Neuropathy (Neuropathy in feet) and Diabetes. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81), ARFORMOTEROL TARTRATE (BROVANA), CARVEDILOL (COREG), RALOXIFENE HYDROCHLORIDE (EVISTA), SITAGLIPTIN PHOSPHATE (JANUVIA), ATORVASTATIN CALCIUM (LIPITOR), MAGNESIUM OXIDE, LEVOTHYROXINE SODIUM (SYNTHROID), VITAMIN D [VITAMIN D NOS], VITAMIN A NOS, FLUOXETINE HYDROCHLORIDE (PROZAC), EZETIMIBE (ZETIA), MONTELUKAST SODIUM (SINGULAIR), OXYBUTYNIN, IRON, VITAMIN C [ASCORBIC ACID] and ALPRAZOLAM (XANAX) for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Felt off and no energy), PAIN (Sore), VACCINATION SITE MASS (A bit of a knot around injection site), VACCINATION SITE PRURITUS (Severely itchy), FATIGUE (Felt tired) and HEADACHE (headache). At the time of the report, ASTHENIA (Felt off and no energy), PAIN (Sore), VACCINATION SITE MASS (A bit of a knot around injection site), FATIGUE (Felt tired) and HEADACHE (headache) outcome was unknown and VACCINATION SITE PRURITUS (Severely itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication including trilogy  was also reported  No treatment medication was reported    Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Concomitant medication list updated, new events updated and start dates updated, second dose details updated On 06-May-2021: Follow-up information received on 06-MAY-2021 contains non-significant information
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of RASH (Rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Vaccination site swelling, Vomiting
Clinical narrative: started experiencing chills; vomiting; headache; swelling at the left arm (the place where the vaccine was injected); This spontaneous case was reported by a physician and describes the occurrence of CHILLS (started experiencing chills), VOMITING (vomiting), HEADACHE (headache) and VACCINATION SITE SWELLING (swelling at the left arm (the place where the vaccine was injected)) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced CHILLS (started experiencing chills), VOMITING (vomiting), HEADACHE (headache) and VACCINATION SITE SWELLING (swelling at the left arm (the place where the vaccine was injected)). At the time of the report, CHILLS (started experiencing chills), VOMITING (vomiting), HEADACHE (headache) and VACCINATION SITE SWELLING (swelling at the left arm (the place where the vaccine was injected)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Swelling on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling on the injection site) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Swelling on the injection site). At the time of the report, VACCINATION SITE SWELLING (Swelling on the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided Treatment Ice pack
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Adverse effect from the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Adverse effect from the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Adverse effect from the vaccine). At the time of the report, VACCINATION COMPLICATION (Adverse effect from the vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment medications was not reported.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Myalgia
Clinical narrative: Covid-19; Coughing; Chills; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19), COUGH (Coughing), CHILLS (Chills) and MYALGIA (Body aches) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced COUGH (Coughing), CHILLS (Chills) and MYALGIA (Body aches). On 28-Mar-2021, the patient experienced COVID-19 (Covid-19). The patient was treated with GUAIFENESIN (MUCINEX) at an unspecified dose and frequency. At the time of the report, COVID-19 (Covid-19), COUGH (Coughing), CHILLS (Chills) and MYALGIA (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided